Evidence map›Paper›PMID 41154151›Full record

ReviewBrain sciences2025

The Role of Psychedelics in the Treatment of Substance Use Disorders: An Overview of Systematic Reviews.

Sabrina Correa da Costa, Nicholas L Bormann, Tyler Oesterle, Michele T McGinnis, Ming-Fen Ho, Sara A Vettleson-Trutza, Teresa Rummans, Mark S Gold

Abstract readReview
In one paragraph

Review in Brain sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sabrina Correa da CostaDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN 55905, USA.
Nicholas L BormannDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0001-8847-8727
Tyler OesterleDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0002-7363-8086
Michele T McGinnisMayo Clinic Libraries, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0009-0005-4893-2530
Ming-Fen HoDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN 55905, USA.
Sara A Vettleson-TrutzaDepartment of Neurologic Surgery, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0009-0005-7065-2439
Teresa RummansDepartment of Psychiatry and Psychology, Mayo Clinic, Jacksonville, FL 32224, USA.ORCID 0000-0002-7967-4766
Mark S GoldDepartment of Psychiatry, Washington University in St. Louis, St. Louis, MO 63130, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

addictionhallucinogensinterventional psychiatryketaminepsychedelicssubstance use disorder (SUD)treatment

Identifiers

PMID41154151
PMCPMC12562643

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.